NEWS & EVENTS
DRAFT FOR RELEASE
October 26, 2009
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Risa Goldman Burgess/Laura Coluci
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
LEERINK SWANN CEO JEFF LEERINK JOINS HARVARD MEDICAL SCHOOL BOARD OF FELLOWS
CEO and Founder of Healthcare-Focused Investment Bank to Advise HMS Dean for Healthcare Education and Research-related Programs
Boston, MA – October 26, 2009 – Leerink Swann, the leading healthcare investment bank, today announced that CEO and Founder Jeffrey A. Leerink has been appointed to the Board of Fellows of the Faculty of Medicine at Harvard Medical School.
The Board of Fellows of the Faculty of Medicine is an advisory group to the Dean of Harvard Medical School, Jeffrey Flier. The board is comprised of scientists, business leaders, healthcare professionals and administrators with expertise in medical science, medicine, healthcare, finance, management, leadership and marketing. Members of the board advise the dean in the areas of their own expertise, and help develop and implement strategies for financing educational and research programs of the Faculty of Medicine.
“I am honored to join this group of esteemed industry professionals to help support the leadership of one of our nation’s finest academic institutions,” said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. “Leerink Swann has always been committed to being the most knowledgeable healthcare investment bank, and this appointment is a strong recognition of the firm’s continued commitment, leadership and presence in the healthcare sector.”
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides capital markets, mergers and acquisition, corporate finance, equity research, asset management and strategic advisory services. Since 1995, Leerink Swann has served as a trusted advisor to corporate, institutional and high-net-worth retail clients. Every year since 2001, Institutional Investor has named Leerink Swann “Best of the Boutiques” in several healthcare categories. Leerink Swann’s proprietary MEDACorp network, comprised of over 30,000 physicians, researchers and healthcare professionals provides unparalleled insights into cutting-edge advances in healthcare. Through its Strategic Advisory group, Leerink Swann provides consulting services to the leaders of healthcare companies and their financial sponsors on the strategic, financial and operational issues that most impact value, growth and profitability. With approximately 250 employees, Leerink Swann has offices in Boston, New York and San Francisco. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.
- END -